APA

Yin X., Ma Q., Mu Q., Shao L., Wang S., Meng H., Xu W., Wang Y., Chen Z., Chen F. & Jin J. (20141118). Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib--a single institution historical experience. : Leukemia research.

Chicago

Yin Xiu-Feng, Ma Qiu-Ling, Mu Qi-Tian, Shao Li, Wang Sha-Sha, Meng Hai-Tao, Xu Wei-Lai, Wang Yun-Gui, Chen Zhi-Mei, Chen Fei-Fei and Jin Jie. 20141118. Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib--a single institution historical experience. : Leukemia research.

Harvard

Yin X., Ma Q., Mu Q., Shao L., Wang S., Meng H., Xu W., Wang Y., Chen Z., Chen F. and Jin J. (20141118). Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib--a single institution historical experience. : Leukemia research.

MLA

Yin Xiu-Feng, Ma Qiu-Ling, Mu Qi-Tian, Shao Li, Wang Sha-Sha, Meng Hai-Tao, Xu Wei-Lai, Wang Yun-Gui, Chen Zhi-Mei, Chen Fei-Fei and Jin Jie. Outcome prediction by the transcript level of BCR-ABL at 3 months in patients with chronic myeloid leukemia treated with imatinib--a single institution historical experience. : Leukemia research. 20141118.